Neogenomics Laboratories

Neogenomics Laboratories company information, Employees & Contact Information

NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company’s Advanced Diagnostics Division serves pharmaceutical clients in clinical trials and drug development. NeoGenomics is committed to connecting patients with life altering therapies and trials. We believe that, together, with our partners, we can help patients with cancer today and the next person diagnosed tomorrow. In carrying out these commitments, NeoGenomics adheres to relevant data protection laws, provides transparency and choice to patients regarding the handling and use of their data through our Notice of Privacy Practices, and has invested in leading technologies to secure the data we maintain. Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories for full-service sample processing in Fort Myers, Florida; Aliso Viejo and San Diego, California; Research Triangle Park, North Carolina; and Houston, Texas; and a CAP accredited full-service, sample-processing laboratory in Cambridge, United Kingdom. NeoGenomics also has several, small, non-processing laboratory locations across the United States for providing analysis services. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and a pharmaceutical firm in Europe.

Company Details

Employees
1.66K
Founded
-
Address
9490 Neogenomics Way, Fort Myers,florida 33912,united States
Phone
(239) 768-0600
Email
hr****@****ics.com
Industry
Hospitals And Health Care
NAICS
Health Care and Social Assistance
Social Assistance
HQ
Fort Myers, Florida
Looking for a particular Neogenomics Laboratories employee's phone or email?

Neogenomics Laboratories Questions

News

NeoGenomics Reports Third Quarter 2025 Results - The AI Journal

NeoGenomics Reports Third Quarter 2025 Results The AI Journal

NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025 - Yahoo Finance

NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025 Yahoo Finance

NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 - Business Wire

NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 Business Wire

NeoGenomics Reports Second Quarter 2025 Results - Yahoo Finance

NeoGenomics Reports Second Quarter 2025 Results Yahoo Finance

NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary - ACCESS Newswire

NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary ACCESS Newswire

NeoGenomics to Participate in Upcoming June Investor Conferences - Business Wire

NeoGenomics to Participate in Upcoming June Investor Conferences Business Wire

NeoGenomics Reports First Quarter 2025 Results - Yahoo Finance

NeoGenomics Reports First Quarter 2025 Results Yahoo Finance

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform - PR Newswire

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform PR Newswire

NeoGenomics Appoints Dr. Marjorie Green to Board of Directors - Yahoo Finance

NeoGenomics Appoints Dr. Marjorie Green to Board of Directors Yahoo Finance

Court Rules for NeoGenomics in Patent Infringement Lawsuit Against Natera - Business Wire

Court Rules for NeoGenomics in Patent Infringement Lawsuit Against Natera Business Wire

NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy - Business Wire

NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy Business Wire

NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer - Business Wire

NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer Business Wire

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results - Yahoo Finance

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results Yahoo Finance

NeoGenomics Completes Acquisition of Pathline - Business Wire

NeoGenomics Completes Acquisition of Pathline Business Wire

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients - Yahoo Finance

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients Yahoo Finance

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline - Business Wire

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline Business Wire

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics - Business Wire

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics Business Wire

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025 - Business Wire

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025 Business Wire

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation - Business Wire

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation Business Wire

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting - Yahoo Finance

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting Yahoo Finance

NeoGenomics Unlocks Next-Gen Cancer Detection With Ultima's Groundbreaking DNA Sequencing - Stock Titan

NeoGenomics Unlocks Next-Gen Cancer Detection With Ultima's Groundbreaking DNA Sequencing Stock Titan

NeoGenomics Announces Chief Executive Officer Succession - Business Wire

NeoGenomics Announces Chief Executive Officer Succession Business Wire

NeoGenomics Stock: Decent Fundamentals, But Still Overvalued (NASDAQ:NEO) - Seeking Alpha

NeoGenomics Stock: Decent Fundamentals, But Still Overvalued (NASDAQ:NEO) Seeking Alpha

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report - ESG Today

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report ESG Today

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment - Stock Titan

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment Stock Titan

NeoGenomics Reports Third Quarter 2023 Results - ACCESS Newswire

NeoGenomics Reports Third Quarter 2023 Results ACCESS Newswire

NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference - The AI Journal

NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference The AI Journal

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment - FinancialContent

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment FinancialContent

NeoGenomics appoints Dr. Shashi Kulkarni, a World-Renowned Oncology Genomics Expert, and Innovator as Chief Scientific Officer - Yahoo Finance

NeoGenomics appoints Dr. Shashi Kulkarni, a World-Renowned Oncology Genomics Expert, and Innovator as Chief Scientific Officer Yahoo Finance

MRD Testing in Solid Tumors Using RaDaR™ by NeoGenomics - Inside Precision Medicine

MRD Testing in Solid Tumors Using RaDaR™ by NeoGenomics Inside Precision Medicine

NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent

NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) FinancialContent

Fort Myers cancer research company NeoGenomics reports record profits - The News-Press

Fort Myers cancer research company NeoGenomics reports record profits The News-Press

Top Neogenomics Laboratories Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant